{"filings":[{"id":1636836,"accession_number":"0001213900-26-077960","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2026-07-14T20:01:41+00:00","items":["8.01"],"status":"ready","headline":"Pluri Inc. EIB loan discussions continue past July 3 deadline; no resolution yet","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["EIB loan of up to €50M; first tranche €20M disbursed June 2021 at 4% interest, originally due June 1, 2026.","EIB confirmed on May 28, 2026 that constructive discussions ongoing; no enforcement expected until July 3, 2026.","After July 3, 2026, discussions continue; EIB indicates progress subject to internal approval and legal review.","No assurance that required approvals will be obtained or that EIB will refrain from exercising remedies.","Company's liquidity and need for additional financing remain key risks."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1609759,"accession_number":"0001213900-26-077548","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2026-07-13T20:05:19+00:00","items":["3.01"],"status":"ready","headline":"Pluri receives Nasdaq delisting notice for failing MVLS minimum of $35M","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on July 7, 2026 for non-compliance with MVLS minimum of $35M.","Also fails alternative standards: stockholders' equity < $2.5M or net income < $500K.","Has 180 days until January 4, 2027 to regain compliance by closing MVLS at $35M+ for 10 consecutive days.","No immediate effect on trading; shares continue on Nasdaq Capital Market under PLUR.","Company evaluating options to regain compliance; no assurance of success."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":"2026-07-13","daily_digest_url":"/daily/2026-07-13","daily_digest_rank":6},{"id":1194638,"accession_number":"0001213900-26-070609","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2026-06-22T20:01:44+00:00","items":["1.01","5.02","5.07","9.01"],"status":"ready","headline":"Pluri receives $1.25M advance from chairman's entity; director Ajchenbaum replaced by founder Shorrer","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Received $1,250,000 advance from Chutzpah Holdings LP (beneficially owned by chairman Alexandre Weinstein) for working capital, to be applied toward future offering by Aug 14, 2026.","Director Eitan Ajchenbaum not re-elected at June 15, 2026 annual meeting; ceased as Audit Committee chair and Investment Committee member.","Board elected Doron Shorrer (company founder, former chairman) to fill vacancy; appointed Audit Committee chair (financial expert) and Investment Committee sole member."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":777918,"accession_number":"0001213900-26-063500","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2026-06-01T20:06:43+00:00","items":["8.01"],"status":"ready","headline":"Pluri gets EIB nod for loan talks; no enforcement until July 3 on €20M maturing today","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["€20M EIB loan at 4% interest matured on June 1, 2026; only first tranche of €50M facility was drawn.","On May 28, 2026, EIB confirmed constructive discussions with Pluri; no enforcement action planned through July 3.","EIB reserved all rights; no assurance that a mutually acceptable resolution will be reached.","Company faces liquidity risk if discussions fail; previous disclosure noted EIB reservation of rights on April 21, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101791,"accession_number":"0001213900-26-035110","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2026-03-27T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Pluri raises $2.5M in private placement to director affiliate; issues shares and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of $2.5M from sale of 625K shares at $4.00 and warrants for 625K shares at $4.25.","Purchaser Chutzpah Holdings LP is beneficially owned by director Alexandre Weinstein.","Proceeds to be used for working capital and general corporate purposes.","Closing expected around end of April 2026, subject to customary conditions.","Warrants exercisable immediately at $4.25 for 18 months, with 35% beneficial ownership limitation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101790,"accession_number":"0001213900-26-022025","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2026-03-02T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Pluri regains Nasdaq compliance on minimum market value requirement","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["On Feb 27, 2026, Nasdaq notified Pluri it regained compliance with Listing Rule 5550(b)(2).","Compliance based on market value of listed securities ≥$35M for 10 consecutive business days (Feb 13–26, 2026).","Prior deficiency letter dated Jan 20, 2026 cited failure to meet $35M market value or alternative standards.","Matter is closed; Pluri remains in good standing on The Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101789,"accession_number":"0001213900-26-006685","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2026-01-22T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Pluri receives Nasdaq delisting notice for failure to meet $35M market value of listed securities","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Pluri on Jan. 20, 2026 that its market value of listed securities fell below the required $35M minimum.","Company also fails alternative listing standards: stockholders' equity < $2.5M or net income from continuing operations < $500K.","Pluri has 180 days (until July 20, 2026) to regain compliance; shares continue trading under PLUR on Nasdaq Capital Market.","If compliance not regained, Nasdaq may delist; Pluri can appeal to a Hearings Panel and potentially stay delisting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118112,"accession_number":"0001213900-25-119651","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2025-12-09T23:59:59+00:00","items":["1.01","3.02","5.02","8.01","9.01"],"status":"ready","headline":"Pluri raises $2.5M via private placement to director; appoints Chairman","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Enters securities purchase agreement for 625,000 common shares and warrants at $4.00/unit; gross proceeds ~$2.5M.","Warrants exercisable at $4.25/share through June 30, 2026; subject to 35% beneficial ownership limitation.","Purchaser is Chutzpah Holdings LP, beneficially owned by director Alexandre Weinstein.","Weinstein appointed Chairman; Zami Aberman appointed Vice Chairman; Aberman's consultancy ends Jan 4, 2026.","RSU grants of 10,248 to CEO/CFO and 2,885 to board members in lieu of cash, vesting over three months."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118111,"accession_number":"0001213900-25-099632","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2025-10-16T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Pluri grants CEO Yaky Yanay 39,050 RSUs and 39,050 stock options for FY2025 performance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved fully vested RSUs (39,050) and options (39,050, $5 strike, 3-yr term) to CEO for FY2025 achievements.","Contingent future grant of 9,266 RSUs and options (same terms) if objectives met by Dec 31, 2025.","Total potential equity: 48,316 RSUs and 48,316 options at $5/share."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134568,"accession_number":"0001213900-25-087052","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2025-09-12T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Pluri regains Nasdaq audit committee independence compliance after electing new director","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Company was non-compliant with Nasdaq Rule 5605(c)(2)(A) after a director failed election at June 30, 2025 annual meeting.","On September 11, 2025, elected Eitan Ajchenbaum as independent director and Audit Committee Chairman.","Nasdaq confirmed compliance regained; matter is now closed.","Cure period under Listing Rule 5605(c)(4) was utilized to resolve the deficiency."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134567,"accession_number":"0001213900-25-086670","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2025-09-11T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Pluri elects Eitan Ajchenbaum to board, fills vacancy left by Doron Birger","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Eitan Ajchenbaum appointed as director effective September 10, 2025, filling board vacancy.","Mr. Ajchenbaum is a CPA with over 30 years experience; currently CFO and Deputy CEO of WeSure Global Tech Ltd.","He will serve as Chairman of the Audit Committee and sole member of the Investment Committee.","Designated as an audit committee financial expert under Regulation S-K.","No family relationships or material transactions with the company disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134566,"accession_number":"0001213900-25-061364","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2025-07-03T23:59:59+00:00","items":["3.01","5.02","5.07"],"status":"ready","headline":"Pluri loses director Birger, triggering Nasdaq audit committee non-compliance with cure period","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Doron Birger not re-elected at June 30 annual meeting; received 1,270,717 for, 2,720,350 against.","Audit Committee now has only 2 independent directors, violating Nasdaq Rule 5605(c)(2)(A).","Nasdaq granted cure period until earlier of next annual meeting or June 30, 2026.","Company intends to appoint an additional independent director to regain compliance.","Shareholders approved 2016 equity plan, advisory vote on exec comp every 2 years, and warrant exercise for Weinstein entity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151423,"accession_number":"0001213900-25-047562","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2025-05-27T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Pluri reschedules 2025 annual meeting to June 30, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Annual meeting moved from May 23 to June 30, 2025, at 4:00 p.m. Israel time.","Record date reset to close of business on May 23, 2025.","Shareholder proposal deadlines (Jan 2, Mar 17) have already passed.","Meeting will be held at company's Haifa office address."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151422,"accession_number":"0001213900-25-040816","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Pluri regains Nasdaq compliance on market value requirement; delisting risk resolved","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["On May 7, 2025, Nasdaq notified Pluri that it has regained compliance with Listing Rule 5550(b)(2) – market value of listed securities >= $35M for 10 consecutive business days (Apr 22 – May 6).","The company had previously received a deficiency notice on Nov 25, 2024 for failing the $2.5M stockholders' equity requirement and alternatives.","Nasdaq granted an extension until May 24, 2025 based on a compliance plan submitted Jan 6, 2025.","The compliance matter is now closed; Pluri remains in good standing on The Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151421,"accession_number":"0001213900-25-036785","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2025-04-29T23:59:59+00:00","items":["5.08"],"status":"ready","headline":"Pluri Inc. sets 2025 Annual Meeting for May 23, 2025; record date March 24","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Meeting to be held May 23, 2025 at 5:00 p.m. Israel time at company headquarters in Haifa.","Record date for voting eligibility set as close of business March 24, 2025.","Shareholder proposals for inclusion in proxy materials must be submitted by January 2, 2025.","Deadline also applies for notice under Rule 14a-19 and discretionary voting authority.","Meeting date is more than 30 days from 2024 anniversary, triggering extended deadlines."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151420,"accession_number":"0001213900-25-035770","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2025-04-28T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Pluri completes acquisition of 71% of Kokomodo Ltd. for $4.5M in shares","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired ~71% equity interest in Kokomodo Ltd. for $4.5 million payable in 976,139 common shares.","Transaction closed on April 28, 2025; Kokomodo will operate as independent majority-owned subsidiary.","Deal details previously disclosed in Form 8-K filed March 13, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151419,"accession_number":"0001213900-25-035668","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2025-04-25T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Pluri exchanges 976,139 shares for pre-funded warrants exercisable after shareholder approval","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Pluri amended the Jan 2025 Securities Purchase Agreement with Chutzpah Holdings (Alejandro Weinstein, director) to exchange 976,139 common shares for pre-funded warrants.","Pre-funded warrants have an exercise price of $0.0001, are exercisable only after Nasdaq-required shareholder approval, and include a 19.99% beneficial ownership limitation.","The exchange is exempt from registration under Section 3(a)(9) of the Securities Act; no new cash was raised.","The amendment also revises the 'Shareholder Approval' definition in the original agreement to cover both existing and new warrants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151418,"accession_number":"0001213900-25-032948","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2025-04-17T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Pluri's subsidiary loses $4.2M NIAID contract for PLX-R18 H-ARS therapy; termination for convenience effective April 15","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Pluri Biotech Ltd. received termination notice from NIAID for a $4.2M contract awarded July 2023 to develop PLX-R18 for Hematopoietic Acute Radiation Syndrome.","Termination effective April 15, 2025, for the government's convenience; Pluri links it to broader federal budgetary adjustments affecting NIH.","Contract involved collaboration with AFRRI and USUHS; company is monitoring potential implications for other programs."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170302,"accession_number":"0001213900-25-025065","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2025-03-19T23:59:59+00:00","items":["5.08"],"status":"ready","headline":"Pluri sets 2025 Annual Meeting for May 14, record date March 24","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Annual Meeting scheduled for May 14, 2025 at 5:00 p.m. Israel time in Haifa, Israel.","Record date for voting eligibility is March 24, 2025.","Deadline for shareholder proposals to be included in proxy materials was January 2, 2025.","Meeting date is more than 30 days from the 2024 Annual Meeting anniversary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170301,"accession_number":"0001213900-25-023733","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2025-03-13T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Pluri to acquire 71.1% of Kokomodo for $4.5M in stock (12.14% dilution); related party deal","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $4.5M payable in 976,139 Pluri common shares (12.14% of fully diluted shares as of Jan 23, 2025).","Acquires 400K ordinary and 175K preferred seed-1 shares representing ~71.1% of Kokomodo equity plus $0.5M convertible loan.","Seller controlled by director Alejandro Weinstein; transaction requires shareholder approval and customary closing conditions.","Breakup fee of $1.5M if deal not closed by May 23, 2025 (extendable to July 23, 2025); payable in shares and SAFE.","Leak-out agreement restricts stock sales to 15% of monthly volume for up to 36 months after closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170300,"accession_number":"0001213900-25-010723","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2025-02-06T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Pluri raises $3.5M via private placement at $4.61/share with warrants to existing shareholder","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of ~$3.5M from sale of 759,219 shares at $4.61 each.","Warrants to purchase 45,553 shares at $5.568 per share, exercisable for 3 years.","Closing expected on or about February 20, 2025; proceeds for working capital.","Merchant Adventure Fund, an existing shareholder, is the sole investor.","Securities issued under Section 4(a)(2) and Rule 506(b) exemption."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170299,"accession_number":"0001213900-25-007698","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2025-01-29T23:59:59+00:00","items":["1.01","3.02","5.02","9.01"],"status":"ready","headline":"Pluri raises $6.5M private placement, signs term sheet to acquire 71% of Kokomodo for $4.5M in stock","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Private placement: 1,383,948 common shares at $4.61 each, plus pre-funded and common warrants; gross proceeds ~$6.5M.","Binding term sheet signed to acquire ~71% of Kokomodo Ltd. for $4.5M payable in common shares; subject to due diligence and shareholder approval.","Alejandro Weinstein appointed to board effective upon closing of the offering; Investor holds ≥10% of shares for continued board seat.","Offering expected to close Jan 31, 2025; Kokomodo Transaction contingent on definitive agreement and Nasdaq approval.","Proceeds from offering to be used for working capital and general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170298,"accession_number":"0001213900-25-004755","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2025-01-21T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Pluri receives Nasdaq extension to May 24, 2025 to regain compliance with stockholders' equity requirement","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Previously reported non-compliance with Nasdaq Listing Rule 5550(b)(1) requiring $2.5M stockholders' equity.","Submitted compliance plan on Jan 6, 2025; Nasdaq granted extension until May 24, 2025.","If not in compliance by deadline, company may face delisting; no immediate effect on trading.","Company intends to take reasonable measures but cannot assure regaining compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187305,"accession_number":"0001213900-24-103469","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2024-11-27T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Pluri receives Nasdaq delisting notice for failing $2.5M equity requirement","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Pluri on Nov 25, 2024 of noncompliance with Listing Rule 5550(b)(1) for stockholders' equity below $2.5M.","Company also fails alternative standards: market value of listed securities ≥ $35M or net income from continuing ops of $500,000.","Pluri has 45 days to submit a compliance plan; Nasdaq may grant up to 180-day extension if plan accepted.","Trading under symbol PLUR continues unaffected pending Nasdaq's review and potential hearing.","Company intends to take all reasonable measures to regain compliance but no assurance of success."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187304,"accession_number":"0001213900-24-083652","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2024-10-01T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Pluri Inc. regains Nasdaq compliance on stockholders' equity requirement","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq letter on Sept 26, 2024 confirming regained compliance with $2.5M stockholders' equity requirement.","Previously deficient as of May 28, 2024; submitted compliance plan on July 11, 2024 and received extension to Nov 24, 2024.","Compliance regained ahead of deadline; Listing Qualifications Department has closed the matter."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203812,"accession_number":"0001213900-24-063305","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2024-07-23T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Pluri receives Nasdaq extension to Nov 24, 2024 to regain $2.5M equity requirement","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Deficiency letter issued May 28, 2024 for failing Nasdaq's $2.5M stockholders' equity minimum.","Compliance plan submitted July 11, 2024; Nasdaq granted extension to November 24, 2024.","If not compliant by deadline, Nasdaq may delist; company may appeal.","No immediate effect on trading of common shares under symbol PLUR.","Company intends to take all reasonable measures to maintain listing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203811,"accession_number":"0001213900-24-059661","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2024-07-08T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Pluri signs €1M proof-of-concept agreement with international agriculture corporation","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Agreement value of €1 million, payable in three installments; first upon signing.","Pluri will apply its 3D cell expansion tech; counterparty provides vegetable-product IP to boost supply.","First payment due on effective date; second after phase 1 completion and go decision; third after phase 2.","Counterparty may terminate within 14 days after either phase's conclusion.","Partnership aims to increase global vegetable supply and combat climate change."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203810,"accession_number":"0001213900-24-058175","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2024-07-02T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Pluri appoints Liat Zalts as CFO effective Sept 30, 2024; Chen Franco-Yehuda resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Chen Franco-Yehuda resigns as CFO, Treasurer and Secretary effective Sept 30 for personal reasons; no disagreement.","Liat Zalts, age 40, appointed CFO and Treasurer effective Sept 30; she was Director of Finance since Dec 2022.","Zalts previously CFO at Matics Manufacturing Analytics (2018–2022) and audit manager at Ernst & Young Israel (2008–2018).","Zalts is a certified public accountant in Israel with degrees from Haifa University and Bar Ilan University."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220412,"accession_number":"0001213900-24-055900","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2024-06-26T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Pluri Inc. holds 2024 annual meeting; all director nominees elected, auditor ratified","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected directors: Aberman, Birger, Levi, Shemesh-Rasmussen, Yanay with strong support (1.6M+ for each).","Auditor Kesselman & Kesselman (PwC) ratified with 2.75M for, 100K against, 8.8K abstain.","Broker non-votes: 1,157,512 on director elections; no broker vote on auditor ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220411,"accession_number":"0001213900-24-053515","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2024-06-18T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Pluri's subsidiary Ever After Foods raises $10M; license expanded to seafood","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Ever After Foods raised $10M in private placement; Pluri invested $1,250,000.","Pluri will own ~69% of Ever After following the closing.","Amended license expands to include fish and seafood; Pluri waives certain royalties.","Proceeds to support Ever After's B2B tech platform for cultivated meat."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220410,"accession_number":"0001213900-24-048443","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2024-05-31T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Pluri receives Nasdaq deficiency notice for failing to meet $2.5M min equity requirement","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received deficiency letter from Nasdaq on May 28, 2024 for non-compliance with minimum stockholders' equity of $2.5M.","Company has 45 calendar days to submit a compliance plan; Nasdaq may grant up to 180-day extension if plan accepted.","Stock continues trading on Nasdaq under symbol 'PLUR' with no immediate effect on listing.","If plan not accepted or compliance not regained, company may request hearing to stay delisting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220409,"accession_number":"0001213900-24-033585","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2024-04-17T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Pluri Inc. regains Nasdaq minimum bid price compliance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Nasdaq staff determined closing bid price ≥ $1.00 for 10 consecutive business days April 1-12, 2024.","Company received compliance letter from Nasdaq on April 15, 2024, closing the matter.","Previously disclosed non-compliance with Nasdaq Listing Rule 5550(a)(2) on April 19, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220408,"accession_number":"0001213900-24-028192","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2024-04-01T23:59:59+00:00","items":["3.03","5.03","9.01"],"status":"ready","headline":"Pluri Inc. announces 1-for-8 reverse stock split effective April 1, 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split ratio of 1-for-8, effective 12:01 a.m. ET on April 1, 2024.","Authorized common shares reduced from 300M to 37.5M; outstanding from 41.8M to approx. 5.23M.","No fractional shares issued; shareholders otherwise receiving a fraction get one additional whole share.","Options, warrants, and convertible securities adjusted by the split ratio; par value unchanged at $0.00001.","Trading symbol PLUR unchanged; new CUSIP 72942G203."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":240055,"accession_number":"0001213900-24-013262","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2024-02-13T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"Pluri Inc. enters into $10M at-the-market equity offering agreement with A.G.P.","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Up to $10M in common shares may be sold from time to time through agent A.G.P.","Sales under effective shelf registration statement (Sept 2023) and prospectus supplement filed Feb 13, 2024.","A.G.P. receives 3.0% cash commission; company reimburses certain expenses.","Company not obligated to sell any shares; no assurance of actual sales.","Sales may be executed as ATM offerings on Nasdaq or in negotiated/block transactions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":240054,"accession_number":"0001213900-24-005861","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2024-01-24T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Pluri launches cell-based coffee business via new PluriAgtech vertical","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["New business vertical PluriAgtech targets sustainable coffee production at mass scale.","Michal Ogolnik appointed to lead PluriAgtech; brings pharma and energy sector experience.","Cell-based coffee addresses growing global demand for sustainable, high-quality coffee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":240053,"accession_number":"0001213900-24-001725","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2024-01-08T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Pluri launches PluriCDMO cell therapy manufacturing division led by Andy Lewin","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["New CDMO division PluriCDMO offers services from preclinical through commercialization.","Division will be led by Andy Lewin, an experienced CDMO executive.","Mission to deliver high-quality essential therapies; no financial guidance provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":257567,"accession_number":"0001013762-23-005107","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2023-10-19T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Pluri receives Nasdaq extension to April 2024 for bid price compliance; transfers to Capital Market","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received 180-day extension until April 15, 2024 to regain minimum $1.00 bid price.","Transfer from Nasdaq Global Market to Nasdaq Capital Market effective October 19, 2023.","Stock continues trading under PLUR; compliance confirmed if bid price >= $1.00 for 10 consecutive days.","Company evaluating measures but no assurance of regaining compliance; delisting risk remains."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":274913,"accession_number":"0001213900-23-056621","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2023-07-13T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Pluri appoints Lorne Abony to board; receives options for 100k shares","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lorne Abony, age 53, appointed effective July 11, 2023; serves on Compensation and Audit Committees.","Abony foregoes cash fees; receives options for 100,000 common shares at $0.76, vesting quarterly over one year.","Abony has board experience at Yooma Wellness, Einride, Amy Insights, VitroLabs; holds MBA from Columbia and JD from Windsor.","No family relationships or related party transactions between Abony and Pluri officers/directors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":274912,"accession_number":"0001213900-23-056039","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2023-07-11T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Pluri signs $4.2M NIAID contract to develop PLX-R18 cell therapy for H-ARS","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Three-year, $4.2M contract with NIAID to advance PLX-R18 for Hematopoietic Acute Radiation Syndrome (H-ARS).","Company will collaborate with U.S. DOD's AFRRI and Uniformed Services University of Health Sciences (USUHS).","Program funded by NIAID, part of the National Institutes of Health (NIH).","PLX-R18 is a potential novel treatment for radiation exposure from nuclear disasters."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":292270,"accession_number":"0001213900-23-033258","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2023-04-27T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Pluri shareholders approve all proposals at 2023 annual meeting, including increase in authorized shares to 300M","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Directors Zami Aberman, Doron Birger, Rami Levi, Maital Shemesh-Rasmussen, Yaky Yanay elected with over 97% of votes cast.","Authorized common shares increased from 60M to 300M; approved by ~93% of votes cast (22.86M for, 1.43M against).","Ratification of PwC as independent auditor for fiscal 2023 passed with ~98% support.","Non-binding advisory vote on executive compensation approved with ~95% of votes cast (15.35M for, 0.73M against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":292269,"accession_number":"0001213900-23-032481","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2023-04-25T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Pluri receives Nasdaq deficiency notice for bid price below $1.00","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Pluri on April 19, 2023 that its common stock bid price closed below $1.00 for 30 consecutive trading days.","Company has 180 calendar days, until October 16, 2023, to regain compliance by closing at $1.00 or more for 10 consecutive business days.","If not compliant by deadline, Pluri may transfer to Nasdaq Capital Market for an additional 180-day cure period or face delisting.","Pluri may consider a reverse stock split or other options to address the deficiency."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312973,"accession_number":"0001213900-23-011032","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K/A","filed_at":"2023-02-14T23:59:59+00:00","items":["5.08"],"status":"ready","headline":"Pluri sets 2023 annual meeting for April 27, record date Feb 27, proposal deadline Feb 15","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["2023 Annual Meeting scheduled for April 27, 2023, at 5:00 p.m. Israel time at company headquarters in Haifa.","Record date for voting is February 27, 2023; proposals for inclusion in proxy materials due by February 15, 2023.","Meeting date differs by >30 days from 2022 annual meeting (June 21, 2022), triggering revised deadlines under Bylaws and Exchange Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312975,"accession_number":"0001213900-23-008270","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2023-02-06T23:59:59+00:00","items":["5.08"],"status":"ready","headline":"Pluri sets 2023 Annual Meeting for April 20; stockholder proposals due by Feb 15","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["2023 Annual Meeting to be held April 20, 2023 at 5:00 p.m. Israel time in Haifa.","Record date for voting is February 27, 2023.","Stockholder proposals for inclusion in proxy materials must be received by Feb 15, 2023.","Director nominations and other business proposals also due by Feb 15, 2023.","Meeting date differs >30 days from 2022 meeting (June 21, 2022), triggering new deadlines."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312974,"accession_number":"0001213900-23-004822","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2023-01-24T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Pluri regains Nasdaq minimum bid price compliance after bid price above $1 for 10 days","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on Jan 23, 2023 that compliance regained as bid price was at least $1.00 for 10 consecutive business days (Jan 6-23).","Previously notified on Oct 12, 2022 of non-compliance with Listing Rule 5550(a)(2).","Matter is now closed; no further action required."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":331496,"accession_number":"0001213900-22-083223","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2022-12-28T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Pluri announces cultivated meat JV with Tnuva reaches proof of concept; CEO takes salary cut for equity","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Joint venture with Tnuva Group reached proof of concept in cultivated meat development using Pluri's 3D cell platform.","New biologics partnership with European API manufacturer for liver and gastroenterological disease treatments.","Company reduced cash burn by ~30% and secured $8.4M new investment via securities purchase agreements.","CEO Yaky Yanay foregoes $375,000 cash salary over 12 months in exchange for equity grants.","EU Horizon Europe awarded €7.5M non-dilutive grant for knee osteoarthritis study using PLX-PAD cells."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":331495,"accession_number":"0001213900-22-080909","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2022-12-19T23:59:59+00:00","items":["1.01","3.02","5.02","9.01"],"status":"ready","headline":"Pluri raises ~$8.4M in private placement of shares and warrants; CEO salary reduction for equity","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Private placement of 8,020,900 common shares at $1.03–$1.09 per share with matching warrants exercisable for 3 years.","Total proceeds ~$8.4 million; closings expected between Dec 15, 2022 and Jan 31, 2023.","CEO Yaky Yanay forgoes $375,000 annual cash salary in 2023 for 334,821 RSUs, 334,821 options at $1.12, plus 1,500,000 performance-vesting options.","Purchasers agree to irrevocable proxy authorizing CEO/CFO to vote shares in favor of increasing authorized shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":331494,"accession_number":"0001213900-22-063839","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2022-10-13T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Pluri receives Nasdaq bid price deficiency notice; has until April 2023 to comply","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Notice on Oct 12, 2022: common stock bid price closed below $1.00 for 30 consecutive days.","180-day compliance period expires April 10, 2023; must close at $1.00+ for 10 consecutive days.","If not compliant by deadline, Company may transfer to Nasdaq Capital Market for additional 180 days.","Company may consider a reverse stock split to regain compliance if appropriate.","Listing continues on Nasdaq Global Market under symbol PLUR during the cure period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":349022,"accession_number":"0001213900-22-059936","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2022-09-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Pluri signs biologics API collaboration, cuts cash burn 30%, holds $56M cash","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["New collaboration with European API manufacturer for liver/gastro drugs; revenue expected in coming months.","Annual cash burn reduced ~30% from $36M to ~$24M; $56M cash at June 30, 2022.","Plurinuva JV with Tnuva: first cultivated meat product in development; proof of concept this year, launch 2023.","Second tech collaboration after Tnuva; targets $366B biologics market, growing to $720B by 2030."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":349021,"accession_number":"0001213900-22-041096","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2022-07-25T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"Pluristem renamed Pluri Inc., ticker PLUR, pivots to multi-industry cell-based platform","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name change from Pluristem Therapeutics Inc. to Pluri Inc. effective July 26, 2022.","Stock ticker symbol changes to 'PLUR' on Nasdaq Global Market.","CEO Yaky Yanay outlines strategic pivot to cell-based technology for food-tech, agri-tech, and biologics.","Commercialization strategy includes licensing and joint ventures ('Pluri focus units') with separate funding and management.","Continues medical research but expands into non-medical cell-based solutions via partnerships."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":349020,"accession_number":"0001213900-22-039009","cik":1158780,"company_name":"Pluri Inc.","ticker":"PLUR","form_type":"8-K","filed_at":"2022-07-13T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Pluristem Phase III hip fracture study misses primary endpoint but meets key secondary muscle strength measure","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Primary endpoint SPPB at week 26 not met; PLX-PAD showed no significant improvement vs placebo.","Hip Abduction Strength (HAS) significantly improved: injured leg +2kg at wk26 (p=0.047) and +4kg at wk52 (p=0.0022).","Uninjured leg also benefited: +1.8kg at wk26 (p=0.073) and +4kg at wk52 (p=0.0046) vs placebo.","6-minute walk test at wk52: PLX-PAD patients walked 296m vs 266m for placebo (positive trend).","Company plans to seek regulatory advice and explore partnerships to advance PLX-PAD development."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":25247536.09322034,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-07-13T23:59:59+00:00|349020"}